Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Percentage calculated based on (a) (1) 306,029 shares of Common Stock, and (2) 202,658 shares of Common Stock issuable on exercise of Series A Warrants, Series B Warrants and Series E Warrants beneficially owned by the reporting person, subject to a 9.9% beneficial ownership limitation, and (b) 8,570,355 shares of Common Stock outstanding on August 4, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Percentage calculated based on (a) (1) 306,029 shares of Common Stock, and (2) 202,658 shares of Common Stock issuable on exercise of Series A Warrants, Series B Warrants and Series E Warrants beneficially owned by the reporting person, subject to a 9.9% beneficial ownership limitation, and (b) 8,570,355 shares of Common Stock outstanding on August 4, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Percentage calculated based on (a) (1) 306,029 shares of Common Stock, and (2) 202,658 shares of Common Stock issuable on exercise of Series A Warrants, Series B Warrants and Series E Warrants beneficially owned by the reporting person, subject to a 9.9% beneficial ownership limitation, and (b) 8,570,355 shares of Common Stock outstanding on August 4, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Percentage calculated based on (a) (1) 306,029 shares of Common Stock, and (2) 202,658 shares of Common Stock issuable on exercise of Series A Warrants, Series B Warrants and Series E Warrants beneficially owned by the reporting person, subject to a 9.9% beneficial ownership limitation, and (b) 8,570,355 shares of Common Stock outstanding on August 4, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025.


SCHEDULE 13G



 
Stonepine Capital Management, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:08/13/2025
 
Stonepine Capital, L.P.
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:08/13/2025
 
Stonepine GP, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:08/13/2025
 
Jon M. Plexico
 
Signature:/s/ Jon M. Plexico
Name/Title:Reporting person
Date:08/13/2025
Exhibit Information

EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G